Evidence map›Paper›PMID 38417977›Full record

ReviewThe lancet. HIV2024

Centring the health of women across the HIV research continuum.

Elizabeth Barr, Leslie J Marshall, Lauren F Collins, Catherine Godfrey, Noelle St Vil, Jamila K Stockman, Dvora L Joseph Davey, Krista Dong, Sarah M Temkin, Mary T Glenshaw and 3 more

Abstract readReview
In one paragraph

Review in The lancet. HIV, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Elizabeth BarrOffice of Research on Women's Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: elizabeth.barr@nih.gov.
Leslie J MarshallOffice of AIDS Research, National Institutes of Health, Bethesda, MD, USA.
Lauren F CollinsEmory University School of Medicine and the Grady Ponce de Leon Center, Atlanta, GA, USA.
Catherine GodfreyOffice of the Global AIDS Coordinator, Department of State, Washington, DC, USA.
Noelle St VilUniversity at Buffalo School of Social Work, Buffalo, NY, USA.
Jamila K StockmanUniversity of California San Diego School of Medicine, San Diego, CA, USA.
Dvora L Joseph DaveyDivision of Infectious Diseases, Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Department of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Krista DongRagon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA; Infectious Diseases Division, Massachusetts General Hospital, Boston, MA, USA.
Sarah M TemkinOffice of Research on Women's Health, National Institutes of Health, Bethesda, MD, USA.
Mary T GlenshawOffice of AIDS Research, National Institutes of Health, Bethesda, MD, USA.
Corette ByrdOffice of AIDS Research, National Institutes of Health, Bethesda, MD, USA.
Janine A ClaytonOffice of Research on Women's Health, National Institutes of Health, Bethesda, MD, USA.
Maureen M GoodenowOffice of the Director, National Institutes of Health, Bethesda, MD, USA.

Funding

HIV-1 and host interactions at molecular levelZIAAI001366 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GOODENOW, MAUREEN · 2023 to 2025
$3.7M
An EYE toward healthy aging in HIV: building evidence for multimorbidity screening and preventionK23AG084415 · NIA · EMORY UNIVERSITY · PI COLLINS, LAUREN FRANCES · 2023 to 2025
$535k
NHLBI NIH HHS L30 HL159721NIA NIH HHS K23 AG084415
6 · The paper itself

Abstract

Despite tremendous advances in HIV research, women and gender diverse people-particularly women from racial and ethnic groups under-represented in research, transgender women, and young women-remain disproportionately affected by HIV. Women and gender diverse people face unique challenges and have been under-represented in HIV research. The National Institutes of Health (NIH) is tasked to apply fundamental knowledge about the nature and behaviour of living systems to enhance health, lengthen life, and reduce disability. Rigorous exploration of-and interventions for-the individual, social, biological, structural, and environmental factors that influence HIV prevention, transmission, treatment, and cure is crucial to advance research for women, girls, and gender diverse people across the lifespan. In this Position Paper, we introduce a framework for an intersectional, equity-informed, data-driven approach to research on HIV and women and highlight selected issues for women and gender diverse people, including HIV prevention, HIV cure, ageing with HIV, substance use and misuse, violence, pregnancy, and breastfeeding or chestfeeding. This framework underlines a new HIV and Women Signature Programme from the NIH Office of AIDS Research and Office of Research on Women's Health that advances the NIH vision for women's health, in which all women receive evidence-based HIV prevention, treatment, and care across their lifespan tailored to their unique needs, circumstances, and goals. The time is now to centre the health of women, girls, and gender diverse people across the HIV research continuum.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsFemaleGender IdentityHumansViolenceWomen's Health

Identifiers

PMID38417977
PMCPMC11301651

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.